Tower Research Capital (TRC)’s Aardvark Therapeutics, Inc. Common Stock AARD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.1K Buy
+1,268
New +$17.1K ﹤0.01% 3757